KFAR SABA, Israel--(BUSINESS WIRE)--Apr 19, 2012-- NLT SPINE, a developer of products aimed for Minimally Invasive Spine Surgery (MISS) and percutaneous procedures, announced today that its eSpin discectomy device has received CE Mark approval, enabling the company to market it in Europe.
eSpin can be used as part of a lumbar interbody fusion procedure, equipping surgeons with a high performance instrument for spinal discectomy. The powered tool evacuates the disc nucleus and can be used to prepare the disc space before placing interbody fusion implants.
The company has recently started using the approved eSpin for discectomy in Europe, and in the future eSpin(TM) will be integrated into NLT SPINE's PROW LIFTM (lumbar interbody fusion) procedures.
"eSpin is only one product of our offering. Our aim is to equip surgeons with a set of products and instruments that are needed to perform complete MISS procedures." said Didier Toubia, CEO, NLT SPINE.
"Receiving the CE Mark for eSpin demonstrates our commitment to the highest standards of quality and functional design, aligned with the strict guidelines of the European regulations for medical devices," he added.
A 510(k) notice for the eSPIN is currently under review by the FDA and the device is not currently for sale in the US. For more information about the company and technology please visit http://www.nlt-spine.com.
About NLT SPINE NLT SPINE specializes in the development of innovative Minimally Invasive Spinal Surgery (MISS) and percutaneous procedures for treating degenerative spinal conditions. The company's vision is to improve patient care and reduce total treatment costs by shifting from traditional open surgical routines to MISS, employing new methods and technologies to enhance usability and outcomes.
Led by top international leaders in spinal surgery, NLT SPINE holds a wide portfolio of pending and issued patents that cover the non-linear core technology and related implant and instrument technologies.
CONTACT: NLT SPINE Tom Keegan Vice President Business Development and US Marketing Tel: 508-272-7750 email@example.com KEYWORD: UNITED STATES EUROPE NORTH AMERICA MASSACHUSETTS MIDDLE EAST ISRAEL INDUSTRY KEYWORD: SURGERY HEALTH BIOTECHNOLOGY CLINICAL TRIALS MEDICAL DEVICES SOURCE: NLT SPINE Copyright Business Wire 2012 PUB: 04/19/2012 07:00 AM/DISC: 04/19/2012 07:00 AM http://www.businesswire.com/news/home/20120419005516/